ARYA Sciences Acquisition Corp.
Status: Deal Closed
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $143.75M |
|---|---|
| IPO Date | Oct 5, 2018 |
| CEO | Adam Stone |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare |
| IPO Geography | Global |
| Target Company | Immatics Biotech |
| Deal Announced | Mar 17, 2020 |
| Deal Size, $M | $314.85M |
| Deal Sector | Healthcare |
| Deal Geography | Europe |
| SEC Filings | www.sec.gov |
| Approval Vote | Jun 29, 2020 |
| Amendment Vote | TBD |
| Closing Date | Jul 1, 2020 |
Formerly ARYA
IMTX
IMTXW
| Price | $7.80 |
|---|---|
| Last closing price | $7.81 |
| H/L, today | $7.46 / $7.89 |
| H/L, 52-week | $5.90 / $13.14 |
| Volume, today | 696,326 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on ARYA Sciences Acquisition Corp.:
- Structure and cap table
- 6 directors & officers
- 25 filings and events
- 2 underwriters
- 8 deal advisors
- 3 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Joseph Edelman | 63 | Chairman |
| Adam Stone | 39 | CEO & Director |
| Michael Altman | 36 | CFO & Director |
| Kevin Conroy | 53 | Director |
| Dr. Todd Wider | 53 | Director |
| Dr. David Hung | 61 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Deal
Sign in to view merger details and deal financials.